https://pharmadog.xyz/news/518903 pharmadog en 2026-10-09T20:27:27.000Z Hospitals file second lawsuit to block Trump admin's 340B rebate pilot https://pharmadog.xyz/news/518982 pharmadog en 2026-10-09T19:08:00.000Z Oliva LLC recalls 250 units of Riad's Oliva to Go dips over undeclared sesame https://pharmadog.xyz/news/518983 pharmadog en 2026-10-09T18:41:00.000Z Krasnyi Oktyabr Recalls Starfish Seafood Trio Over Listeria Risk https://pharmadog.xyz/news/518415 pharmadog en 2026-10-09T18:28:05.000Z Curium lists Bexlutry at $63,524 per infusion, roughly 5% cheaper than Novartis' Lutathera https://pharmadog.xyz/news/518123 pharmadog en 2026-10-09T16:33:55.000Z Pharma gifts and payments to doctors linked to higher inappropriate prescribing, study finds https://pharmadog.xyz/news/517955 pharmadog en 2026-10-09T15:55:47.000Z Humana tops 2027 Medicare Advantage star ratings as insurers face $13 billion in bonus payouts and legal challenges https://pharmadog.xyz/news/517956 pharmadog en 2026-10-09T15:41:39.000Z Life Biosciences injects experimental cellular reprogramming drug into three glaucoma patients, reports no serious adverse events https://pharmadog.xyz/news/517975 pharmadog en 2026-10-09T15:18:00.000Z FDA review flags limited efficacy of Revolution's pancreatic cancer drug Rasonque, shares drop 6% https://pharmadog.xyz/news/517911 pharmadog en 2026-10-09T15:17:24.000Z RevMed's Rasonque shows weaker response in common KRAS pancreatic cancer mutation, shares fall over 6% https://pharmadog.xyz/news/517743 pharmadog en 2026-10-09T14:43:11.000Z Acting HHS General Counsel Bob Foster Departs Agency https://pharmadog.xyz/news/517699 pharmadog en 2026-10-09T14:28:00.000Z Biotech Index Retraces Gains as Weak Trial Data and Market Fears Weigh https://pharmadog.xyz/news/517635 pharmadog en 2026-10-09T14:15:32.000Z City Therapeutics plans $158 million IPO as Iambic eyes $135 million Nasdaq debut https://pharmadog.xyz/news/134233 pharmadog en 2026-10-09T14:06:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/517511 pharmadog en 2026-10-09T13:59:35.000Z Q32 Bio appoints José Trevejo as chief medical officer, coming from Enveda Therapeutics https://pharmadog.xyz/news/517491 pharmadog en 2026-10-09T13:33:53.000Z TRexBio and Retension raise $161.7M in IPOs as biotech fundraising surge continues https://pharmadog.xyz/news/517512 pharmadog en 2026-10-09T13:23:29.000Z Proposed Census Overhaul Could Undermine Public Health Data, Experts Warn https://pharmadog.xyz/news/517513 pharmadog en 2026-10-09T13:17:20.000Z FDA flags safety concern after four deaths in schizophrenia drug trial https://pharmadog.xyz/news/517323 pharmadog en 2026-10-09T11:58:39.000Z Viatris to acquire Pacira BioSciences for $1.65 billion to expand non‑opioid pain portfolio https://pharmadog.xyz/news/517155 pharmadog en 2026-10-09T11:54:09.000Z Novartis licenses Abogen’s mRNA CD19×CD3 engager in $575M upfront deal https://pharmadog.xyz/news/517131 pharmadog en 2026-10-09T11:00:53.000Z AI startup Chai Discovery inks GSK deal to develop biologics using artificial intelligence https://pharmadog.xyz/news/517132 pharmadog en 2026-10-09T11:00:33.000Z Viking Therapeutics commercial chief exits after nine months; Gilead eyes BeOne executive for China growth https://pharmadog.xyz/news/517027 pharmadog en 2026-10-09T10:59:00.000Z TRex Bio prices $117M IPO to fund Treg-targeted immune therapies https://pharmadog.xyz/news/517718 pharmadog en 2026-10-09T10:37:00.000Z GSK partners with Chai Discovery to use AI protein-folding models after successful wet-lab tests https://pharmadog.xyz/news/518390 pharmadog en 2026-10-09T09:07:00.000Z BD appoints Ferass Abuzaina as Worldwide President of Surgery https://pharmadog.xyz/news/516673 pharmadog en 2026-10-09T08:30:00.000Z Half-century after IL-2 discovery, its impact on HIV, cancer and blood safety is highlighted https://pharmadog.xyz/news/516674 pharmadog en 2026-10-09T08:30:00.000Z Researcher uses Reddit data to map post-Roe abortion access barriers https://pharmadog.xyz/news/516672 pharmadog en 2026-10-09T08:30:00.000Z Proposed US Census rule changes could distort health data, warns epidemiologist https://pharmadog.xyz/news/516671 pharmadog en 2026-10-09T08:30:00.000Z MAHA movement fades as midterms approach, lacking visibility and funding https://pharmadog.xyz/news/516459 pharmadog en 2026-10-09T07:54:45.000Z TRexBio raises $117 million in IPO as Retension secures $45 million Nasdaq debut for hypertension therapy https://pharmadog.xyz/news/517106 pharmadog en 2026-10-09T07:32:00.000Z Fierce Biotech outlines criteria for its 2026 Fierce 15 list, spotlighting top innovators https://pharmadog.xyz/news/517442 pharmadog en 2026-10-09T04:59:00.000Z Nobel-winning optogenetics sees growing biotech interest https://pharmadog.xyz/news/516770 pharmadog en 2026-10-09T04:31:00.000Z Lilly-backed TRex Bio raises $117M in IPO as hypertension biotech Retension secures $45M listing https://pharmadog.xyz/news/518015 pharmadog en 2026-10-09T04:00:00.000Z FDA issues early alert on Philips Lumify ultrasound system software and connection problems https://pharmadog.xyz/news/515003 pharmadog en 2026-10-08T23:09:27.000Z Trump administration probes nine top universities over alleged J-1 visa misuse for postdocs https://pharmadog.xyz/news/514667 pharmadog en 2026-10-08T21:44:05.000Z Congressional Bill Aims to End Arbitration in No Surprises Act, Shifting Payments to Median In-Network Rates https://pharmadog.xyz/news/517532 pharmadog en 2026-10-08T20:57:00.000Z HHS unveils new vaccine injury surveillance plan with NIH clinic and reporting reimbursements https://pharmadog.xyz/news/514203 pharmadog en 2026-10-08T19:06:10.000Z Eli Lilly’s trillion-dollar market cap mirrors Dodgers’ big-spending dominance https://pharmadog.xyz/news/514204 pharmadog en 2026-10-08T19:05:19.000Z ARM playbook proposes data reuse to slash gene-editing R&D costs and broaden rare-disease therapies https://pharmadog.xyz/news/514011 pharmadog en 2026-10-08T18:55:11.000Z New PDUFA agreement earmarks funds to rehire FDA reviewers after recent layoffs https://pharmadog.xyz/news/514055 pharmadog en 2026-10-08T18:50:54.000Z NIH funding uncertainty clouds US research, dampens biotech investor sentiment https://pharmadog.xyz/news/514012 pharmadog en 2026-10-08T18:13:05.000Z Viatris to acquire Pacira BioSciences for $1.65 billion, expanding its non‑opioid pain portfolio https://pharmadog.xyz/news/513675 pharmadog en 2026-10-08T16:27:16.000Z Robotics biotech firm Multiply Labs raises $75M Series B as NorthStar secures up to $185M https://pharmadog.xyz/news/513739 pharmadog en 2026-10-08T16:00:00.000Z Viatris to acquire Pacira BioSciences for $1.65 billion, adding two non-opioid pain drugs https://pharmadog.xyz/news/513551 pharmadog en 2026-10-08T15:43:59.000Z AI tool for breast cancer risk moves to direct-to-consumer amid regulatory scrutiny of Utah sandbox https://pharmadog.xyz/news/513571 pharmadog en 2026-10-08T15:38:00.000Z Argenx shares tumble 15% after Phase 3 Sjögren’s study of Vyvgart halted for futility https://pharmadog.xyz/news/513443 pharmadog en 2026-10-08T15:31:38.000Z Democrats eye key House committees as midterms approach, opening doors for new health policy influence https://pharmadog.xyz/news/513399 pharmadog en 2026-10-08T15:30:49.000Z Ono Pharmaceutical pays Biohaven $80 million for protein degrader as UK pulls Valneva's chikungunya vaccine https://pharmadog.xyz/news/513400 pharmadog en 2026-10-08T15:29:56.000Z Endeavor BioMedicines reports mid-stage trial success for IPF drug, suggests disease reversal potential https://pharmadog.xyz/news/517274 pharmadog en 2026-10-08T15:24:00.000Z Vir Biotechnology appoints David Liu as chief medical officer to steer hepatitis D phase 3 and cancer programs https://pharmadog.xyz/news/513463 pharmadog en 2026-10-08T15:23:00.000Z Caribou Biosciences explores strategic alternatives, drawing interest as a reverse-merger candidate https://pharmadog.xyz/news/513444 pharmadog en 2026-10-08T15:18:05.000Z Roche partners with Chinese biotech Defand Therapeutics to co-develop new medicines https://pharmadog.xyz/news/513401 pharmadog en 2026-10-08T15:12:53.000Z WHO and biotech firms turn attention to preeclampsia, a leading cause of maternal and newborn complications https://pharmadog.xyz/news/513423 pharmadog en 2026-10-08T15:08:54.000Z Argenx halts late-stage Vyvgart trial in Sjogren’s disease after futility finding, shares tumble 13% https://pharmadog.xyz/news/518014 pharmadog en 2026-10-08T15:08:00.000Z Par Health recalls two lots of Brevital Sodium injection over cellulose particles https://pharmadog.xyz/news/513445 pharmadog en 2026-10-08T15:02:53.000Z FDA extends safety review of mifepristone into next year, report due by March 2027 https://pharmadog.xyz/news/513402 pharmadog en 2026-10-08T15:02:27.000Z Grindr launches telehealth service offering erectile dysfunction and weight loss prescriptions https://pharmadog.xyz/news/513231 pharmadog en 2026-10-08T14:41:14.000Z Zealand and Roche report positive Phase 2 results for amylin drug petrelintide in obesity and diabetes https://pharmadog.xyz/news/513275 pharmadog en 2026-10-08T14:02:29.000Z Argenx's Vyvgart fails to beat placebo in Phase 3 Sjögren's disease trial https://pharmadog.xyz/news/513087 pharmadog en 2026-10-08T13:51:02.000Z Newron reports five deaths in schizophrenia trial as FDA keeps hold on evenamide study https://pharmadog.xyz/news/513088 pharmadog en 2026-10-08T13:40:59.000Z Zealand Pharma’s petrelintide shows 9% weight loss in Phase 2 but fails to improve blood sugar, analysts unimpressed https://pharmadog.xyz/news/513063 pharmadog en 2026-10-08T13:25:15.000Z General Medicine secures $120 million to launch all-in-one healthcare marketplace https://pharmadog.xyz/news/513107 pharmadog en 2026-10-08T13:15:33.000Z PhRMA sues Trump administration over Medicare price linking pilot program https://pharmadog.xyz/news/513089 pharmadog en 2026-10-08T13:04:15.000Z Matchpoint Therapeutics raises $150 million Series B to move oral T-cell modulator MPT-062 toward clinical trials https://pharmadog.xyz/news/512771 pharmadog en 2026-10-08T12:00:00.000Z Roche partners with China's Defand Therapeutics to discover molecular glue medicines https://pharmadog.xyz/news/512772 pharmadog en 2026-10-08T11:53:27.000Z All 2026 Nobel laureates in science are men, highlighting ongoing gender gap https://pharmadog.xyz/news/512559 pharmadog en 2026-10-08T11:00:06.000Z Argenx halts Phase 3 Sjögren's trial as celiac disease data brings mixed results https://pharmadog.xyz/news/512415 pharmadog en 2026-10-08T09:52:54.000Z Venture debt becomes central financing option for late-stage European biotech https://pharmadog.xyz/news/513038 pharmadog en 2026-10-08T09:36:00.000Z Endeavor BioMedicines reports positive phase 2b results for Hedgehog inhibitor taladegib in IPF https://pharmadog.xyz/news/513039 pharmadog en 2026-10-08T08:46:00.000Z Iambic Therapeutics targets $135M IPO to fund clinical trials of HER2 and KIF18A cancer drugs https://pharmadog.xyz/news/512273 pharmadog en 2026-10-08T08:30:00.000Z Mother and daughter seek community for ultra-rare Nicolaides-Baraitser syndrome https://pharmadog.xyz/news/512268 pharmadog en 2026-10-08T08:30:00.000Z Democrats compete for new seats on House Energy and Commerce and Ways and Means committees after midterms https://pharmadog.xyz/news/512272 pharmadog en 2026-10-08T08:30:00.000Z Tailored breast cancer care for older women gains momentum as researchers highlight age-specific tumor differences https://pharmadog.xyz/news/512270 pharmadog en 2026-10-08T08:30:00.000Z Experts say U.S. must step up to match Europe’s progress in eliminating hepatitis C https://pharmadog.xyz/news/512267 pharmadog en 2026-10-08T08:30:00.000Z Smaller biotech firms face uncertainty over U.S. tariff exemptions as new import taxes take effect https://pharmadog.xyz/news/512269 pharmadog en 2026-10-08T08:30:00.000Z CMS proposes changes to curb 340B drug discount program’s costly subsidies to safety-net hospitals https://pharmadog.xyz/news/512271 pharmadog en 2026-10-08T08:30:00.000Z Everlywell launches AI tool to predict breast cancer risk directly to consumers https://pharmadog.xyz/news/511779 pharmadog en 2026-10-08T06:44:11.000Z Roche signs near-$1 billion partnership with Chinese biotech Defand on degrader therapies https://pharmadog.xyz/news/512366 pharmadog en 2026-10-08T05:25:00.000Z Ono Pharmaceutical pays $80 million for Asian rights to Biohaven IgG degrader trio, including phase-3 Graves disease candidate https://pharmadog.xyz/news/512367 pharmadog en 2026-10-08T04:34:00.000Z Zealand's amylin analog shows strong weight loss but weak blood-sugar control in phase 2 trial https://pharmadog.xyz/news/511467 pharmadog en 2026-10-08T04:31:00.000Z Rare disease biotech firms expand teams as FDA approvals boost pipelines https://pharmadog.xyz/news/511468 pharmadog en 2026-10-08T04:01:00.000Z Q3 biopharma layoffs drop 90% year-over-year, affecting about 1,800 workers https://pharmadog.xyz/news/512198 pharmadog en 2026-10-08T03:04:00.000Z Argenx’s FB102 meets primary endpoint in phase 2 celiac trial, paving way for pivotal study https://pharmadog.xyz/news/514865 pharmadog en 2026-10-08T00:00:00.000Z FDA unveils transparency roadmap with plans for public NDA/BLA disclosures and inspection report publishing https://pharmadog.xyz/news/514866 pharmadog en 2026-10-08T00:00:00.000Z EU Commission urges EMA to fast-track Biotech Act preparations